Related Experiment Video

Updated: Aug 30, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Bcl-2 antisense oligonucleotides: a potential novel strategy for the treatment of breast cancer

Rita Nahta1, Francisco J Esteva

  • 1Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Seminars in Oncology
|November 13, 2003
PubMed

Insights

Bcl-2 (B-cell lymphoma 2) overexpression in breast cancer hinders apoptosis, potentially reducing chemotherapy effectiveness. Bcl-2 antisense therapy aims to re-sensitize tumors to treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Bcl-2 (B-cell lymphoma 2) is a key inhibitor of apoptosis.
  • Overexpression of Bcl-2 is prevalent in numerous human cancers, including 40-80% of breast tumors.
  • Bcl-2's role as an independent prognostic marker in breast cancer is limited due to its association with hormone receptors.

Purpose of the Study:

  • To investigate the role of Bcl-2 in breast cancer apoptosis and chemosensitivity.
  • To evaluate the potential of Bcl-2 antisense oligonucleotides as a therapeutic strategy.

Main Methods:

  • Review of existing literature on Bcl-2 expression in breast cancer.
  • Analysis of the association between Bcl-2, hormone receptors, and therapeutic response.
  • Examination of preclinical data on Bcl-2 downregulation using antisense oligonucleotides.

Main Results:

  • Bcl-2 overexpression is linked to resistance to chemotherapeutic drugs by diminishing apoptosis.
  • Downregulation of Bcl-2 via antisense oligonucleotides has shown promise in enhancing chemotherapy efficacy in experimental models.
  • Ongoing Phase III trials are evaluating Bcl-2 antisense therapy in solid tumors.

Conclusions:

  • Bcl-2 antisense-based therapy is a viable strategy for inducing apoptosis in cancer cells.
  • This approach holds potential for enhancing the chemosensitivity of breast cancers and other solid tumors.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...